Skip to content

about
services
insights
careers
contacts

story
board of directors
ethics & compliance
environmental, social & governance
principles
services
insights
careers
contacts

TPG Invests $75 Million into Precision For Medicine – PharmaLive

PMG Staff2015-12-22T16:03:52-05:00News|

PharmaLive covers TPG’s significant investment in Precision Medicine Group

Share

facebook twitter linkedin Email

FEATURED

Precision Medicine Group Welcomes Margaret Keegan as CEO. Read the press release

Recent Posts

Precision Medicine Group Announces Key Leadership Appointments
Precision Medicine Group Welcomes Margaret Keegan as CEO
Now Available On Demand: Cell & Gene Day, 2024
Conference: Meeting on the Med, 2024
Conference: Gene Therapy for Rare Disorders (GTRD), 2024

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

services
careers
environmental, social & governance
contacts
Aetna MRF

© Precision Medicine Group, LLC.
All Rights Reserved.

Privacy Policy GDPR